Investors give biotechs injection of funds Hobart’s weather is bracing at this time of the year (maybe understating things a tad) but there was a much warmer…
Bharat Biotech’s intranasal COVID-19… Hyderabad: Vaccine maker Bharat Biotech’s intranasal vaccine for COVID-19, the first in the world, is scheduled to…
Moderna’s mRNA cancer vaccine trial is ‘big step… Moderna’s mRNA cancer vaccine combined with a Merck treatment immunotherapy slashed the risk of melanoma coming…
Biotechs look to sell royalties to raise cash in… Biotechs are turning to specialist royalty companies to generate cash from future sales of their products,…
InnovationRx: FDA Greenlights Omicron Boosters;… InnovationRx is your weekly digest of healthcare news. To get it in your inbox, subscribe here. getty Earlier…
Bharat Biotech’s intranasal Covid vaccine… Hyderabad: Vaccine-maker Bharat Biotech announced on Monday that its intranasal vaccine for Covid-19 has been…
Biotechs face ‘funding Sahara’ as easy money… As Genocea ran low on cash in 2018, investors offered the US biotech a lifeline that allowed it to shift focus from…
Biotechs face cash crunch after stock market… Dozens of biotech companies are running low on cash and face an uphill struggle to raise fresh funds after…
FirstFT: Biotechs face cash crunch Good morning. This article is an on-site version of our FirstFT newsletter. Sign up to our Asia,…